Chapter

The current status of migraine therapy

F. Clifford Rose

in Migraine: A Spectrum of Ideas

Published in print March 1990 | ISBN: 9780192618108
Published online March 2012 | e-ISBN: 9780191724305 | DOI: http://dx.doi.org/10.1093/acprof:oso/9780192618108.003.0024
The current status of migraine therapy

Show Summary Details

Preview

A recent method of preventing migraine attack has been tried on patients with premonitory symptoms, for example, irritability, excitement, euphoria, or food cravings that occur as long as twenty-four hours before the attack; these patients have been given domperidone, a dopamine D2 receptor antagonist, which is anti-emetic (that is, relieving nausea and vomiting) and gastro-kinetic (that is, stimulating the stomach and opening the pyloric spincter so that oral medication can be absorbed by the small gut). With premonitory symptoms of more than six hours, it can be effective in preventing migraine attacks. There is still no general agreement as to how migraine is best treated, largely because of the fact that many drugs which are used have not been scientifically evaluated by methodologically sound clinical trials.

Keywords: migraine therapy; migraine attacks; drug use; clinical trials; domperidone; premonitory symptoms

Chapter.  6046 words. 

Subjects: Neuroscience

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.